Variant: rs735665

present in Gene: GRAMD1B present in Chromosome: 11 Position on Chromosome: 123490689 Alleles of this Variant: G/A

rs735665 in GRAMD1B gene and Chronic Lymphocytic Leukemia PMID 22700719 2012 Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

PMID 18758461 2008 We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)).

PMID 24292274 2014 A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.

PMID 23770605 2013 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.

rs735665 in GRAMD1B gene and Erectile dysfunction PMID 22704111 2012 Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT/EDIC study cohort.

rs735665 in GRAMD1B gene and Lymphoma, Follicular PMID 20639881 2010 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

rs735665 in GRAMD1B gene and Mature B-Cell Neoplasm PMID 20639881 2010 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

rs735665 in GRAMD1B gene and Nasopharyngeal carcinoma PMID 20512145 2010 A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.

rs735665 in GRAMD1B gene and Small Lymphocytic Lymphoma PMID 22700719 2012 Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

PMID 18758461 2008 A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.

PMID 23770605 2013 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.

PMID 24292274 2014 A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.